Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MAP3K2 anticorps

MAP3K2 Reactivité: Humain ELISA, ICC Hôte: Souris Monoclonal 4B4 unconjugated
N° du produit ABIN969272
  • Antigène Voir toutes MAP3K2 Anticorps
    MAP3K2 (Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2))
    Reactivité
    • 46
    • 29
    • 14
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 45
    • 2
    Souris
    Clonalité
    • 38
    • 9
    Monoclonal
    Conjugué
    • 20
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp MAP3K2 est non-conjugé
    Application
    • 29
    • 20
    • 14
    • 4
    • 3
    • 2
    • 1
    • 1
    ELISA, Immunocytochemistry (ICC)
    Fonction
    MAP3K2 Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of human MAP3K2 expressed in E. Coli.
    Clone
    4B4
    Isotype
    IgG1
  • Indications d'application

    ELISA: 1/10000

    ICC: 1/200 - 1/1000

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Kurada, Li, Mulherkar, Subramanian, Prasad, Prabhakar: "MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment." dans: The Journal of biological chemistry, Vol. 284, Issue 20, pp. 13533-41, (2009) (PubMed).

    Cazares, Troyer, Mendrinos, Lance, Nyalwidhe, Beydoun, Clements, Drake, Semmes: "Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, Issue 17, pp. 5541-51, (2009) (PubMed).

  • Antigène
    MAP3K2 (Mitogen-Activated Protein Kinase Kinase Kinase 2 (MAP3K2))
    Autre désignation
    MAP3K2 (MAP3K2 Produits)
    Synonymes
    anticorps Mekk2, anticorps MEKK2, anticorps MEKK2B, anticorps 9630061B06Rik, anticorps AI585793, anticorps Mekk2b, anticorps mitogen activated protein kinase kinase kinase 2, anticorps mitogen-activated protein kinase kinase kinase 2, anticorps Map3k2, anticorps MAP3K2
    Sujet

    Description: The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process.

    Aliases: MEKK2, MEKK2B

    Poids moléculaire
    70kDa
    ID gène
    10746
    HGNC
    10746
    UniProt
    Q9Y2U5
    Pathways
    Signalisation MAPK
Vous êtes ici:
Support technique